● Recruiting

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Condition: Obstructive Cardiomyopathy, Hypertrophic · Non-obstructive Hypertrophic Cardiomyopathy · Sponsor: Lexicon Pharmaceuticals

PhasePhase 3

Planned participants500

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (HCM) treated with sotagliflozin as compared to placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Tracy Newbold · 281-863-3016 · tnewbold@lexpharma.com

Always discuss trial participation with your own doctor first.

Locations (108)

Lexicon Investigational Site (4041)	Phoenix, Arizona, United States	Recruiting
Lexicon Investigational Site (4037)	Scottsdale, Arizona, United States	Recruiting
Lexicon Investigational Site (4012)	Los Angeles, California, United States	Recruiting
Lexicon Investigational Site (4035)	Pomona, California, United States	Recruiting
Lexicon Investigational Site (4044)	San Francisco, California, United States	Recruiting
Lexicon Investigational Site (4046)	Jacksonville, Florida, United States	Recruiting
Lexicon Investigational Site (4034)	Orlando, Florida, United States	Recruiting
Lexicon Investigational Site (4018)	Atlanta, Georgia, United States	Recruiting
Lexicon Investigational Site (4033)	Evanston, Illinois, United States	Recruiting
Lexicon Investigational Site (4036)	Merrillville, Indiana, United States	Recruiting
Lexicon Investigational Site (4021)	Baltimore, Maryland, United States	Recruiting
Lexicon Investigational Site (4016)	Boston, Massachusetts, United States	Recruiting

+ 96 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06481891